Aspira Pathlab & Diagnostics Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002885,
    "name": "Aspira Pathlab",
    "stock_name": "Aspira Pathlab",
    "full_name": "Aspira Pathlab & Diagnostics Ltd",
    "name_url": "stocks-analysis/aspira-pathlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "119.70",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "119.70",
    "mcapval": "123.21 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540788,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE500C01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": 254,
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 109",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-of-rs109-4000524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_4000524.png",
        "date": "2026-05-20 09:40:48",
        "description": "With a remarkable 70.29% gain over the past seven days, Aspira Pathlab &amp; Diagnostics Ltd surged to a fresh 52-week high of Rs 109 on 20 Jun 2026, defying the broader market's subdued tone and showcasing a powerful technical momentum that has captivated attention."
      },
      {
        "title": "When is the next results date for Aspira Pathlab & Diagnostics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aspira-pathlab-diagnostics-ltd-3999789",
        "imagepath": "",
        "date": "2026-05-19 23:18:48",
        "description": "The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 23 May 2026...."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 104.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs10452-3998579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_3998579.png",
        "date": "2026-05-19 09:41:08",
        "description": "With a sustained six-day rally delivering a 63.85% gain, Aspira Pathlab &amp; Diagnostics Ltd surged to a fresh 52-week high of Rs 104.52 on 19 Jun 2026, outpacing its healthcare services peers and the broader market."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-ltd-upgraded-to-sell-on-technical-improvements-despite-valuation-concerns-3998414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_mojoScore_3998414.png",
        "date": "2026-05-19 09:00:01",
        "description": "Aspira Pathlab & Diagnostics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators. However, valuation metrics and financial trends continue to weigh on the stock’s outlook, reflecting a complex investment case amid mixed signals from market data and company fundamentals."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd: Valuation Shift Signals Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-valuation-shift-signals-price-attractiveness-decline-3997882",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_valuationdot_3997882.png",
        "date": "2026-05-19 08:02:24",
        "description": "Aspira Pathlab & Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting investors to reassess its price attractiveness amid strong recent returns and a micro-cap status within the healthcare services sector."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Hits New 52-Week High of Rs 81.21 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-hits-new-52-week-high-at-rs8121-3989053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AspiraPathlabDi_priceRelatedfactors_3989053.png",
        "date": "2026-05-13 09:44:03",
        "description": "Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 81.21 on 13 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical alignment and sustained upward price action over recent sessions."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd Falls to 52-Week Low of Rs 49 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-falls-to-52-week-low-of-rs49-3947617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AspiraPathlabDi_priceRelatedfactors_3947617.png",
        "date": "2026-04-15 12:10:15",
        "description": "A sharp decline in Aspira Pathlab & Diagnostics Ltd has pushed the stock to a fresh 52-week low of Rs 49 on 15 Apr 2026, marking a significant 39.5% drop from its 52-week high of Rs 81. This comes amid heightened volatility and a continuation of recent losses, despite some contrasting financial signals."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-ltd-is-rated-strong-sell-3941524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AspiraPathlabDi_mojoScore_3941524.png",
        "date": "2026-04-10 10:10:24",
        "description": "Aspira Pathlab &amp; Diagnostics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 10 April 2026, providing investors with an up-to-date view of the company’s position."
      },
      {
        "title": "Aspira Pathlab &amp; Diagnostics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-strong-sell-3923830",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AspiraPathlabDi_mojoScore_3923830.png",
        "date": "2026-03-30 10:10:17",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the company’s current position as of 30 March 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 15,
    "sid": "1002885",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/aspira-pathlab-diagnostics-1002885"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "11-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deepali Arvind Bhanushali & PACs",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "11-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shraddha Bhanushali & PACs",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "11-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Raj Arvind Bhanushali & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 109

2026-05-20 09:40:48

With a remarkable 70.29% gain over the past seven days, Aspira Pathlab & Diagnostics Ltd surged to a fresh 52-week high of Rs 109 on 20 Jun 2026, defying the broader market's subdued tone and showcasing a powerful technical momentum that has captivated attention.

When is the next results date for Aspira Pathlab & Diagnostics Ltd?

2026-05-19 23:18:48

The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 23 May 2026....

Broad-Based Technical Strength Lifts Aspira Pathlab & Diagnostics Ltd to 52-Week High of Rs 104.52

2026-05-19 09:41:08

With a sustained six-day rally delivering a 63.85% gain, Aspira Pathlab & Diagnostics Ltd surged to a fresh 52-week high of Rs 104.52 on 19 Jun 2026, outpacing its healthcare services peers and the broader market.

Aspira Pathlab & Diagnostics Ltd Upgraded to Sell on Technical Improvements Despite Valuation Concerns

2026-05-19 09:00:01

Aspira Pathlab & Diagnostics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators. However, valuation metrics and financial trends continue to weigh on the stock’s outlook, reflecting a complex investment case amid mixed signals from market data and company fundamentals.

Aspira Pathlab & Diagnostics Ltd: Valuation Shift Signals Price Attractiveness Decline

2026-05-19 08:02:24

Aspira Pathlab & Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting investors to reassess its price attractiveness amid strong recent returns and a micro-cap status within the healthcare services sector.

Aspira Pathlab & Diagnostics Ltd Hits New 52-Week High of Rs 81.21 on Back of Strong Technical Signals

2026-05-13 09:44:03

Surging past its previous peaks, Aspira Pathlab & Diagnostics Ltd reached a fresh 52-week high of Rs 81.21 on 13 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical alignment and sustained upward price action over recent sessions.

Aspira Pathlab & Diagnostics Ltd Falls to 52-Week Low of Rs 49 as Sell-Off Deepens

2026-04-15 12:10:15

A sharp decline in Aspira Pathlab & Diagnostics Ltd has pushed the stock to a fresh 52-week low of Rs 49 on 15 Apr 2026, marking a significant 39.5% drop from its 52-week high of Rs 81. This comes amid heightened volatility and a continuation of recent losses, despite some contrasting financial signals.

Aspira Pathlab & Diagnostics Ltd is Rated Strong Sell

2026-04-10 10:10:24

Aspira Pathlab & Diagnostics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 10 April 2026, providing investors with an up-to-date view of the company’s position.

Aspira Pathlab & Diagnostics Ltd is Rated Strong Sell

2026-03-30 10:10:17

Aspira Pathlab & Diagnostics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the company’s current position as of 30 March 2026, providing investors with the latest insights into its performance and outlook.

View All News